Alan Bash
Biotech executive and company leader with prior roles at Bristol-Myers Squibb and as CEO of Checkmate Pharmaceuticals and Zeal Bio; currently President of Carvykti at Legend Biotech overseeing commercialization of the BCMA CAR-T therapy Carvykti.
Best podcasts with Alan Bash
Ranked by the Snipd community
Mar 23, 2026 • 51min
Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash
Alan Bash, biotech executive who led programs at BMS and ran Checkmate and Zeal Bio, now heads Carvykti commercialization at Legend Biotech. He discusses scaling autologous CAR T manufacturing and the Legend–J&J partnership. He covers strategies to expand patient access, educational outreach, preparing for BCMA competitors, and upcoming pipeline moves into allogeneic and in vivo approaches.
